Related Experiment Video
Updated: Jul 17, 2025

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
NaV1.7: A central role in pain
Stephen G Waxman1, Sulayman D Dib-Hajj1
1Department of Neurology, Yale University, New Haven, CT 06520; Center for Neuroscience & Regeneration Research, Yale University, New Haven, CT 06520; Center for Rehabilitation Research, VA Connecticut Healthcare System, West Haven, CT 06516.
Loss of function in the sodium channel NaV1.7 causes pain insensitivity. New research shows that blocking this channel for pain relief does not rely on enkephalin, highlighting its independent role in pain signaling.
Area of Science:
- Neuroscience
- Pain Research
- Ion Channel Biology
Background:
- The sodium channel NaV1.7 is crucial for pain signaling.
- Loss-of-function mutations in NaV1.7 lead to congenital insensitivity to pain.
- Understanding the precise mechanisms of NaV1.7-mediated analgesia is essential for developing novel pain therapeutics.
Purpose of the Study:
- To investigate the role of enkephalins in analgesia resulting from NaV1.7 inhibition.
- To determine if enkephalin overexpression is a compensatory mechanism for NaV1.7 loss or blockade.
- To elucidate the independent contribution of NaV1.7 to nociceptor function and pain perception.
Main Methods:
- Utilized genetic models and pharmacological blockade to inhibit NaV1.7 function.
- Assessed changes in enkephalin levels and expression in relevant tissues.
- Evaluated pain responses and nociceptor activity following NaV1.7 manipulation.
Main Results:
- Analgesia achieved through NaV1.7 removal or blockade was not associated with increased enkephalin levels.
- Enkephalin overexpression was not observed as a compensatory mechanism in response to NaV1.7 inhibition.
- NaV1.7 plays a critical role in nociceptor firing and pain transmission, independent of endogenous opioid pathways.
Conclusions:
- The analgesic effects of NaV1.7 inhibition are independent of the enkephalinergic system.
- NaV1.7 is a key determinant of pain perception, functioning separately from endogenous opioid-mediated analgesia.
- These findings reinforce NaV1.7 as a vital target for pain management strategies that do not rely on opioid pathways.
Related Concept Videos
Nociception
Pain
Analgesia and Pain Management
Mechanically-gated Ion Channels
Thermosensation
Local Anesthetics: Differential Sensitivity of Nerve Fibers

